| Trial ID: | L0625 |
| Source ID: | NCT05264584
|
| Associated Drug: |
Isotonic Saline
|
| Title: |
Renoprotective Effect of Febuxostat on Contrast Induced Acute Kidney Injury in Chronic Kidney Disease Patients Stage 3
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Chronic Kidney Disease stage3|Contrast-induced Nephropathy
|
| Interventions: |
DRUG: Isotonic saline|DRUG: N-acetyl cysteine|DRUG: Febuxostat 80 MG
|
| Outcome Measures: |
Primary: prevention of CI-AKI, incidence of CI-AKI after 48-72 hours after PCI, 48-72 hours post contrast |
|
| Sponsor/Collaborators: |
Sponsor: Ain Shams University
|
| Gender: |
ALL
|
| Age: |
CHILD, ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
120
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: PREVENTION
|
| Start Date: |
2020-12-01
|
| Completion Date: |
2022-02-01
|
| Results First Posted: |
|
| Last Update Posted: |
2022-03-25
|
| Locations: |
Ain shams university hospitals, Cairo, 1181, Egypt
|
| URL: |
https://clinicaltrials.gov/show/NCT05264584
|
